Body mass index predicts major bleeding risks in patients on warfarin

Despite the lack of an optimum dosing strategy in obese patients, warfarin remains the most commonly used anticoagulant. Body mass index (BMI) >30 has been linked to increased time to obtain a therapeutic international normalized ratio on initiation of warfarin as well as higher maintenance dose....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2015-11, Vol.40 (4), p.494-498
Hauptverfasser:	Ogunsua, Adedotun A., Touray, Sunkaru, Lui, Justin K., Ip, Tiffany, Escobar, Jorge V., Gore, Joel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Aged, 80 and over Body Mass Index Cardiology Female Hematology Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Male Medicine Medicine & Public Health Middle Aged Obesity Retrospective Studies Risk Factors Sex Factors Warfarin - administration & dosage Warfarin - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!